2020 has been a memorable year in science for many reasons, most of them bad. As we finally begin to see some chinks of light at the end of this incredibly long year, the Opinionated Science team look back at some of the biggest stories of the year that were nothing to do with COVID-19, including brain implants, inherited trauma and millions of tons of microplastics.
This episode is a COVID-19 podcast with a first-hand focus. Podcast host Ruairi Mackenzie discusses his experience with symptomatic COVID-19. And we also look at the data around COVID-19 risk and age and discuss the emerging problems posed by long COVID.
In this episode, the team discuss the growing movement for sustainable science. Research has a yeti-sized ecological footprint, and here we follow the tracks from ozone-destroying CFCs and energy-guzzling freezers through to a new future for science that promises to make labs eco-friendly at last.
In this episode, the team take a deep dive into the world of biohacking. Practitioners of this DIY biology have big goals: making genetic technologies available to all, bypassing government regulation of drugs and (on the fringes of the movement) achieving immortality.
In this episode, the TN team discuss three promising vaccine candidates being developed for COVID-19. We take a deep dive into the data from these vaccine trials to try and work out what successes can be celebrated and what unanswered questions still remain.
Opinionated Science Episode 9: The Ethics of Genetics Testing: “Duty of Care”, Consent and Data SecurityPodcast
Advances in genetic testing have come with a lot of ethical baggage. In this podcast we discuss how clinical testing can throw up surprise results for doctor and patient, the test data that is helping fight COVID-19 and how one of our own editors responded to receiving her genetic risk scores.
In this episode, we review the evidence surrounding vagus nerve stimulation (VNS), a therapy approved for epilepsy and depression that backers now want to use to treat a host of other conditions, include autoimmune disease and heart failure. How can scientists fill in the gaps in the VNS knowledge base?